TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 9.38
-0.09 (-0.90%)
Sep 11, 2026, 4:08 PM HKT
HKG:2617 Revenue
TransThera Sciences (Nanjing) had revenue of 35.46M CNY in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 35.46M.
Revenue (ttm)
35.46M CNY
Revenue Growth
n/a
P/S Ratio
94.28
Revenue / Employee
268.60K CNY
Employees
132
Market Cap
3.86B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.18M | 1.06M | 852.42% |
| Dec 31, 2022 | 124.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.